Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Protein Shake up: FAIRR’s $1TRN Investor Coalition Turns up the Heat on Meat

FAIRR
Posted on: 26 Sep 16

A $1.25 trillion coalition of 40 institutional investors, includingSwedish state pensionfunds AP2, AP3 and AP4, Aviva Investors, Boston Common, Coller Capital, Folksam, Nordea and Robeco, has launched an engagement with 16 multinational food companies highlighting the material risks posed by industrial animal production. The coalition is urging companies to identify their plans to respond to this risk, in particular by encouraging them to set strategies to diversify into plant-based sources of protein.

Backed by a new briefing entitled ‘The future of food - the investment case for a protein shake up, the investors warn of the risks associated with the growing global demand for protein and an overreliance on the unsustainable factory farming of livestock for its supply. The briefing highlights the environmental, social and public health risks inherent in this model, which financial markets are not currently valuing appropriately.

The companies being engaged include Kraft Heinz, Nestle, Unilever, Tesco, Walmart and General Mills, which holds its AGM in Minneapolis tomorrow. The coalition has been brought together by the FAIRR (Farm Animal Investment Risk & Return) Initiative, in partnership with responsible investment organisation ShareAction. US food giant General Mills - makers of Häagen Dazs and Yoplait - is highlighted as an example of good practice f`or supporting start-up companies such as Beyond Meat, which is developing foods to substitute meat products with more sustainable plant-based alternatives.

Jeremy Coller, Founder of the FAIRR Initiative and CIO of Coller Capital, said:

“The world’s overreliance on factory farmed livestock to feed the growing global demand for protein is a recipe for a financial, social and environmental crisis. Intensive livestock production already has levels of emissions and pollution that are too high, and standards of safety and welfare that are too low. It simply can’t cope with the projected increase in global protein demand. Investors want to know if major food companies have a strategy to avoid this protein bubble and to profit from a plant-based protein market set to grow by 8.4% annually over the next five years.”

`The analysis report also points to regulatory trends as a driver for corporate action – such as Denmark’s consultation on the introduction of red meat tax and the Chinese government’s plan to reduce its citizens’ meat consumption by 50%.

Clare Richards, Campaigns Manager at ShareAction said:

“The trend for ‘less but better meat’ is creating new opportunities on plates and in portfolios. Evidence suggests that plant-based protein sources are better for your health, your wallet, and the planet. Consumers increasingly recognise these benefits; and now this coalition of forward-thinking investors are doing the same. As a result of this engagement we hope more companies will embrace the opportunities presented by this growing consumer trend.”

Peter van der Werf, Engagement Specialist at Robeco said:

"The growing demand for meat will put large pressure on natural resources in the coming decades. Robeco identified this as a financial material topic and engages to improve sustainability in the meat supply chain. Protein diversification is an important instrument to that end. Companies at the end of the meat supply chain have an important role to play towards customers and we will encourage them to make protein diversification an integral part of their strategy."

END

View source version on businesswire.com: http://www.businesswire.com/news/home/20160926005093/en/

Business Wire
www.businesswire.com

Last updated on: 26/09/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.